Active

Vives Partners

Investor type

VC

Founded

2004

AUM

$141 M

Location

Wavre, Walloon Region, Belgium

Investment Ticket

$1-5 m

Investment Stage

Series A Series B

Region of investment

Europe

ESG Focus

Impact investor
Investor profile last updated: 13 October, 2026

Profile

Vives Partners is a venture capital firm based in Belgium that focuses on early-stage investments, particularly in university spin-offs and innovative startups. Established in 2004, the firm is initiated by UCLouvain and collaborates closely with other universities and incubators across Europe. Vives Partners maintains a small team of investment professionals who leverage their academic and industry networks to identify and support promising ventures that have the potential to deliver societal impact.

Vives Partners has a multi-sectoral investment strategy, focusing on industries such as biotechnology, healthtech, and technology, with a particular emphasis on projects that deliver a positive societal impact. The firm typically invests in Series A and B rounds with check sizes ranging from $1-5 million. Their funds under management total about €128 million, with their latest being the €70 million VIVES Inter-University Fund.

Notable investments by Vives Partners include ATB Therapeutics - targeted cancer therapy, ViroVet - antiviral treatments for livestock, BiocSol - advanced biopesticides, Generare - molecular data generation, and Bionyra Pharma - next-generation biologics for inflammatory diseases.

Industry

HealthTech Internet of Things (IoT) Technology Pharmaceuticals Medical Devices Biotechnology

Vives Partners Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
VIVES Inter-University Fund
Venture Capital (VC)
Biotechnology
Medical Devices
Pharmaceuticals
Technology
Internet of Things (IoT)
HealthTech
Series A
Series B
Europe
$1-5 m
—
October 2026

Contacts

Name
Title
Email
Upgrade to see contacts
avatar
qPOxnNl50sL2ah4T qPOxnNl50sL2ah4T
qPOxnNl50sL2ah4T
avatar
qPOxnNl50sL2ah4T qPOxnNl50sL2ah4T
qPOxnNl50sL2ah4T
avatar
qPOxnNl50sL2ah4T qPOxnNl50sL2ah4T
qPOxnNl50sL2ah4T
avatar
qPOxnNl50sL2ah4T qPOxnNl50sL2ah4T
qPOxnNl50sL2ah4T
avatar
qPOxnNl50sL2ah4T qPOxnNl50sL2ah4T
qPOxnNl50sL2ah4T
Investment-team contacts for Vives Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Vives Partners

Vives Partners is a venture capital firm. It backs companies at Series A and Series B, writing tickets of $1-5 m.
Vives Partners is located in Wavre, Walloon Region, Belgium.
Vives Partners was founded in 2004.
Vives Partners invests in companies and startups in HealthTech, Internet of Things (IoT), Technology, Pharmaceuticals, Medical Devices, Biotechnology.
Vives Partners invests in companies and startups in Europe.
Vives Partners invests in companies and startups at Series A, Series B.
Vives Partners usually invests $1-5 m on average.
Vives Partners has around $141m assets under management.
Yes, Vives Partners is impact investor.
Vives Partners can be reached through its website vivesfund.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Vives Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Vives Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 13 October, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.